ImmuPharma PLC (IMM)
LSE
Real-time Data
07:00 AM
Day's Range
3.4052 wk Range
1.50Overview - IMM - ImmuPharma PLC
Key Statistics
Valuation
Enterprise Value
18.70M
P/E (Forward)
‪-0.01‬
PEG Ratio
‪-0.01‬
Price / Book
‪3,989.99‬
EV / EBITDA
‪-7.48‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-110.91%‬
Return on Equity
‪-2,510.60%‬
Ownership
Shares Outstanding
502.72M
Float
486.38M
Held by Insiders
‪4.97%‬
Held by Institutions
‪19.38%‬
Price stats
Beta
‪3.01‬
50-Day Avg
‪4.01‬
200-Day Avg
‪5.46‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - IMM - ImmuPharma PLC
Peers - IMM - ImmuPharma PLC
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- IMMLSEImmuPharma PLC2.48BMarket Cap+60.15%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0MGBLSEGenmab A/S168.24BMarket Cap+25.25%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.31BMarket Cap+29.11%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+30.71%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0A45LSEModerna, Inc.66.31BMarket Cap+81.03%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.88%52-week change127.93P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - IMM - ImmuPharma PLC
About
ImmuPharma PLC is a clinical-stage specialty biopharmaceutical company focused on discovering and developing peptide-based therapeutics to tackle autoimmune diseases and infectious diseases. Its primary mission centers on curing autoimmune conditions by addressing root causes through innovative precision therapies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
